Continuous glucose monitoring: A review of the technology and clinical use

Klonoff, David C.; Ahn, David; Drincic, Andjela

doi:10.1016/j.diabres.2017.08.005

Cited by 222 publications

(174 citation statements)

References 70 publications

Supporting

Mentioning

168

Contrasting

Unclassified

Order By: Relevance

“…In addition, patients were recruited from education sessions and clinic visits, which could lead to selecting more motivated individuals who have been shown to have better outcomes with CGM . However, demographics were similar in both the overall paediatric clinic and the study population, except for a slightly higher use of insulin pumps.…”

Section: Discussionmentioning

confidence: 99%

“…This gives patients a better understanding of their glucose levels and helps them identify trends, allowing proactive rather than reactive adjustment of insulin doses and carbohydrate consumption. Thus, it has the potential to reduce glycaemic variability, a risk factor for vascular disease independent of HbA 1c . Sensor results can be transmitted to remote smart phones or devices, notifying a patient or carer if sensor glucose value deviates from the normal range, reducing the need for overnight finger‐prick testing.…”

mentioning

confidence: 99%

“…CGM sensors must therefore be calibrated, usually twice daily, ideally when glucose levels are stable. Inaccurate, more or less frequent calibrations can introduce error …”

mentioning

confidence: 99%

See 2 more Smart Citations

Sydney Diabetes centre's experience of the Australian Government's roll out of subsidised continuous glucose monitoring for children with type 1 diabetes mellitus

Sandy

Nyunt

Woodhead

et al. 2018

J Paediatrics Child Health

View full text Add to dashboard Cite

Aim To determine patient/carer expectations of continuous glucose monitoring (CGM) and short‐term satisfaction, to assess the efficacy of CGM in improving: fear of hypoglycaemia and glycaemic control (HbA1c, ketosis, hypoglycaemia) and to determine time requirements of diabetes clinic staff in commencing and administering CGM. Methods We assessed CGM‐naïve patients starting on CGM at a Sydney Diabetes Centre following the introduction of a nationwide government subsidy for CGM. A standardised questionnaire was administered collecting demographic and glycaemic information in addition to Likert scale assessment of expectations and satisfaction. Clinic staff reported time dedicated to CGM education, commencement and follow‐up. Results A total of 55 patients or parents/carers completed baseline questionnaires, with 37 completing a 3‐month follow‐up questionnaire. There were high expectations of CGM prior to commencement and high satisfaction ratings on follow‐up. CGM improved fear of hypoglycaemia, and total daily insulin dose increased after commencement of CGM. There was a trend towards lower HbA1c that was not statistically significant and no statistically significant reduction in ketosis or hypoglycaemia. Comments were mostly positive, with some concern raised regarding technical issues and a lack of subsidy after 21 years of age. Staff time requirements were substantial, with an estimated average of 7.7 h per patient per year. Conclusions Patients and families have high expectations of CGM, and satisfaction levels are high in the short term. Total insulin delivery increased after CGM commencement. Time requirements by staff are substantial but are worthwhile if families' overall satisfaction levels are high.

show abstract

Section: Discussionmentioning

confidence: 99%

mentioning

confidence: 99%

See 1 more Smart Citation

Sydney Diabetes centre's experience of the Australian Government's roll out of subsidised continuous glucose monitoring for children with type 1 diabetes mellitus

Sandy

Nyunt

Woodhead

et al. 2018

J Paediatrics Child Health

View full text Add to dashboard Cite

show abstract

“…Also, the use of vasoconstrictor drugs decreases blood flow to the skin and results in a slower shift of glucose from capillaries to the interstitial fluid compartment. Some other clinical conditions include hypotension, hypoxemia, and the use of high‐dose acetaminophen in intensive care units adversely affect the accuracy of CGM sensors as well …”

Section: Clinical Indications For Cgm Technologymentioning

confidence: 99%

“…Some other clinical conditions include hypotension, hypoxemia, and the use of high-dose acetaminophen in intensive care units adversely affect the accuracy of CGM sensors as well. 75…”

Section: Introduction Of Cgmmentioning

confidence: 99%

Chinese clinical guidelines for continuous glucose monitoring (2018 edition)

Bao

Chen

et al. 2019

Diabetes Metabolism Res

View full text Add to dashboard Cite

Summary Blood glucose monitoring is an important part of diabetes management. Continuous glucose monitoring (CGM) technology has become an effective complement to conventional blood glucose monitoring methods and has been widely applied in clinical practice. The indications for its use, the accuracy of the generated data, the interpretation of the CGM results, and the application of the results must be standardized. In December 2009, the Chinese Diabetes Society (CDS) drafted and published the first Chinese Clinical Guideline for Continuous Glucose Monitoring (2009 edition), providing a basis for the standardization of CGM in clinical application. Based on the updates of international guidelines and the increasing evidence of domestic studies, it is necessary to revise the latest CGM guidelines in China so that the recent clinical evidence can be effectively translated into clinical benefit for diabetic patients. To this end, the CDS revised the Chinese Clinical Guideline for Continuous Glucose Monitoring (2012 Edition) based on the most recent evidence from international and domestic studies.

show abstract